Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, discovery, and clinical development of targeted radiotherapies. It also develops and markets medicines for relapsed and refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
25
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Actinium Pharmaceuticals Inc market cap is $46.85M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Actinium Pharmaceuticals Inc 52 week high is $1.72 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Actinium Pharmaceuticals Inc 52 week low is $0.7351 as of November 17, 2026.
Actinium Pharmaceuticals Inc stock price today is $1.33.
Actinium Pharmaceuticals Inc stock price yesterday was $1.49.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Actinium Pharmaceuticals Inc's P/E ratio is 4.18.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Actinium Pharmaceuticals Inc P/B ratio is 1.546.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Actinium Pharmaceuticals Inc 50-day moving average is $1.29.